Persistent hunger or cravings
Appetite that feels difficult to regulate despite thoughtful nutrition efforts.
Home / Clinical Peptide Therapy / Women
A women-first program · physician-crafted & managedPeptide Program
for Women
You do not need to understand peptide chemistry before asking for help. Tell us what has changed. We will investigate the whole picture, explain what is—and is not—supported by evidence, and build a plan only if treatment is appropriate.
Ageless AI Before & After Experience
See Your Future Self after therapy.
Picture the woman you are working toward. Create a motivational AI visualization, bring that vision to your consultation and use it to talk about the health, confidence and sustainable changes that matter to you.
The Ageless preview opens in a new tab and is operated by a third party. Review its displayed privacy information before uploading a photograph or personal information.
The Simple Version
Peptides are messenger molecules.
Think of a peptide as a short biological message. Some prescription medicines are engineered to send a very specific signal—such as helping regulate appetite. But “peptide therapy” is not one universal treatment, and common symptoms do not prove that your body is “low in peptides.” A physician first has to determine what may be driving the symptoms.
Not a vitaminPeptide medicines act on specific receptors and can have meaningful risks.
Not one-size-fits-allYour diagnosis, medications and reproductive plans matter.
Not a promiseTreatment response and side effects vary from person to person.
Start With What You Notice
Could this conversation be for you?
These concerns deserve evaluation, but none of them alone establishes a need for peptide therapy.
Weight or waist changes
Increasing weight, central weight gain or metabolic risk that may meet criteria for medical weight management.
Low energy
Fatigue can relate to sleep, iron deficiency, thyroid disease, menopause, medication effects and many other causes.
Poor sleep
Restless sleep, snoring or waking unrefreshed should prompt a broader sleep and health evaluation.
Low desire with distress
Sexual-health concerns are real and often multifactorial. One peptide medicine has a narrow FDA-approved use in certain premenopausal women.
Life-stage changes
Perimenopause and menopause can affect sleep, body composition and desire—but peptide treatment is not a default substitute for evidence-based menopause care.
Symptoms are clues, not a diagnosis.
Your clinician may recommend laboratory testing, sleep evaluation, nutrition support, menopause care, mental-health support or another pathway instead of—or alongside—any peptide-based medicine.
Who May Be a Candidate?
Candidacy begins with a defined clinical need.
A consultation may make sense if…
- You have obesity, or overweight plus a weight-related condition, and want a medically supervised plan
- You have tried sustainable nutrition and activity changes but need additional clinical support
- You have acquired, generalized low sexual desire with distress and want a complete evaluation
- You want medication status, expected benefit, cost and alternatives explained clearly
- You can participate in follow-up and report side effects promptly
Treatment may be unsafe or inappropriate if…
- You are pregnant, trying to conceive or breastfeeding
- You or your family have a history relevant to labeled thyroid-tumor warnings, including MTC or MEN 2
- You have certain severe gastrointestinal, pancreatic, gallbladder or other medical concerns
- A medication interaction or uncontrolled condition makes the risk unacceptable
- The proposed product is unverified, research-only or does not fit a diagnosed need
This is not a complete eligibility list. A licensed clinician must review the current label and your individual history.
What the Data Actually Say
Evidence with the fine print included.
Semaglutide trial average
In STEP 1, mean weight change at 68 weeks was 14.9% with semaglutide versus 2.4% with placebo, both with lifestyle intervention. Adults had overweight or obesity and did not have diabetes. Primary study.
Tirzepatide trial averages
At 72 weeks in SURMOUNT-1, mean loss ranged from 15.0% to 20.9% across doses versus 3.1% with placebo. Gastrointestinal adverse events were most common. Primary study.
Bremelanotide is not a general libido booster
Its FDA-approved use is acquired, generalized hypoactive sexual desire disorder in premenopausal women, excluding cases explained by another condition, relationship problem or medication. FDA label.
Women-Specific Safety
Pregnancy plans and birth control belong in the first conversation.
Weight-loss medications are not used during pregnancy. The current Wegovy label instructs patients to stop semaglutide at least two months before a planned pregnancy. Tirzepatide delays gastric emptying and may reduce the effectiveness of oral hormonal contraceptives after starting treatment and after each dose increase.
- Tell us if pregnancy is possible or planned
- Discuss non-oral or backup contraception with tirzepatide
- Review every medication and supplement
- Report severe or persistent abdominal symptoms
- Never use research-only injections
Wegovy prescribing informationPregnancy, contraindications and labeled safety information.Open current FDA label
Zepbound prescribing informationPregnancy and oral hormonal contraceptive precautions.Open current FDA label
Your Care Path
Designed around you—not a trend.
Tell your story
Symptoms, goals, prior attempts, life stage and what feels sustainable.
Clinical evaluation
History, medications, reproductive plans, vitals and labs when indicated.
Your options
A transparent discussion of evidence, alternatives, risks and product status.
Active follow-up
Tolerability, nutrition, strength, response and dose decisions are monitored.
The Total Woman Program
Connect physician-guided weight management, nutrition, aesthetics and women’s wellness in one coordinated journey.
Explore the ProgramClinical Peptide Therapy
Learn the difference between FDA-approved, compounded and investigational products.
Visit the Clinical HubPeptide Program for Men
A distinct men’s pathway for weight, sleep, energy and sexual-health concerns.
Explore the Men’s ProgramEvidence reviewed September 3, 2026 · Prepared under the Identity Aesthetics medical editorial standard. Educational content is not medical advice.
Start With a Real ConversationYou bring the symptoms.
You bring the symptoms.
We build the clinical picture.
Book a women-focused clinical peptide consultation in office or ask whether telehealth is available for your location and needs.